Transfusion and Apheresis Science
Volume 42, Issue 1 , Pages 39-42 , February 2010

Thrombotic thrombocytopenic purpura as the first manifestation of metastatic adenocarcinoma in a young woman

  • Gurhan Kadikoylu

      Affiliations

    • Adnan Menderes University Medical Faculty, Division of Hematology, 09100 Aydin, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 256 4441256; fax: +90 256 2146495.
    • ,
  • Sabri Barutca

      Affiliations

    • Adnan Menderes University Medical Faculty, Division of Oncology, Aydin, Turkey
    • ,
  • Canten Tataroglu

      Affiliations

    • Adnan Menderes University Medical Faculty, Division of Pathology, Aydin, Turkey
    • ,
  • Samet Kafkas

      Affiliations

    • Adnan Menderes University Medical Faculty, Divisions of Obstetrics and Gynecology, Aydin, Turkey
    • ,
  • Hakan Erpek

      Affiliations

    • Adnan Menderes University Medical Faculty, Division of General Surgery, Aydin, Turkey
    • ,
  • Nezih Meydan

      Affiliations

    • Adnan Menderes University Medical Faculty, Division of Oncology, Aydin, Turkey
    • ,
  • Irfan Yavasoglu

      Affiliations

    • Adnan Menderes University Medical Faculty, Division of Hematology, 09100 Aydin, Turkey
    • ,
  • Zahit Bolaman

      Affiliations

    • Adnan Menderes University Medical Faculty, Division of Hematology, 09100 Aydin, Turkey

Received 29 October 2008 ,Revised 17 December 2008 ,Accepted 20 January 2009.

References 

  1. McCrae KR, Sadler JE, Cines D. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. In: Hoffman R, Benz Jr EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al., editors. Hematology, basic principles and practice. 4th ed. Philadelphia: Elsevier Churchill Livingstone; 2005. p. 2287–2304.
  2. Moake JL. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Semin Hematol. 2004;41:4–14
  3. Fontana S, Hovinga JA, Taleghani BM. Treatment of thrombotic thrombocytopenic purpura. Vox Sang. 2006;90:245–254
  4. Mori Y, Wada H, Okugawa Y, Tamaki S, Nakasaki T, Watanabe R, et al. Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Clin Appl Thromb Hemost. 2001;7:5–9
  5. Kobayashi M, Wada H, Wakita Y, Shimura M, Nakase T, Hiyoyama K, et al. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura. Thromb Haemost. 1995;73:10–14
  6. Wu X-W, Li Q-Z, Lian ECY. Plasma from a patient with thrombotic thrombocytopenic purpura induces endothelial cell apoptosis and platelet aggregation. Thromb Res. 1999;93:79–87
  7. Anthony MT, Zella ZR, Lister J, Raymond JM, Shadduck RK, Kramer RE, et al. Plasminogen activator inhibitor-1 (PAI-1) antigen levels in primary TTP and secondary TTP post bone marrow transplantation. Am J Hematol. 1998;59:9–14
  8. Kwaan HC, Gordon LI. Thrombotic microangiopathy in the cancer patient. Acta Haematol. 2001;106:52–56
  9. Chang JC, Naqvi T. Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer. Oncologist. 2003;8:375–380
  10. Matsumoto M, Yagi H, Ishizashi H, Wada H, Fujimura Y. The Japanese experience with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome. Semin Hematol. 2004;41:68–74
  11. Miller DP, Kaye JA, Shea K, Ziyadeh N, Cali C, Black C, et al. Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Epidemiology. 2004;15:208–215
  12. Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, et al. Cancer-associated hemolytic uremic syndrome. Analysis of 85 cases from a national registry. J Clin Oncol. 1989;6:781–789
  13. George JN. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006;354:1927–1935
  14. Young RH. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II. Adv Anat Pathol. 2007;14:149–177
  15. Sifil A, Akarsu M, Karadas A, Cavdar C, Yorukoglu K, Camsan T. A patient with thrombotic thrombocytopenic purpura treated as systemic lupus erythematosus initially. Office J Turkish Nephorol Assoc. 1999;1:43–45[Turkish]
  16. Jolin JA, Rapkin A. Pelvic pain and dysmenorrhea. In:  Berek JS editors. Novak’s gynecology. 13th ed.. Philadelphia: Lippincott Williams-Wilkins; 2002;p. 421–452
  17. Rock GA. Management of thrombotic thrombocytopenic purpura. Brit J Haematol. 2000;109:496–507
  18. Werner TL, Agarwal N, Carney HM, Rodgers GM. Management of cancer-associated thrombotic microangiopathy: what is the right approach?. Am J Hematol. 2007;82:295–298
  19. von Bubnoff N, Sandherr M, Schneller F, Peschel C. Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast. Am J Clin Oncol. 2000;23:74–77
  20. Antman KH, Skarin AT, Mayer RJ, Hargreaves HK, Canellos GP. Microagniopathic hemolytic anemia and cancer: a review. Medicine. 1979;58:377–384
  21. Zupancic M, Shah PC, Shah-Khan F, Nagendra S. Gemcitabine associated thrombotic thrombocytopenic purpura. Lancet Oncol. 2007;8:634–641
  22. Studt JD, Kremer Hovinga JA, Alberio L, Bianchi V, Lammle B. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory. Swiss Med Wkly. 2003;133:325–332
  23. Qu L, Kiss JE. Thrombotic microangiopathy in transplantation and malignancy. Semin Thromb Hemost. 2005;31:691–699
  24. Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: a report of 10 patients and systematic review of published. Oncologist. 2007;12:11–19
  25. Sndyer HW, Mittelman A, Oral A, Messerschmidt GL, Korec S, Bertam JH, et al. Treatment of cancer-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer. 1993;71:1882–1892
  26. Gonzalez N, Rios E, Martin-Noya A, Rodriguez JM. Thrombotic thrombocytopenic purpura and bone marrow necrosis as a complication of gastric neoplasm. Haematologica. 2002;87:ECR01

PII: S1473-0502(09)00178-5

doi: 10.1016/j.transci.2009.10.010

Transfusion and Apheresis Science
Volume 42, Issue 1 , Pages 39-42 , February 2010

Article Tools

* Image Usage & Resolution